femtherapeutics

FemTherapeutics Inc. is a Canadian medical device company based in Montreal, Quebec, founded in 2019. The company focuses on personalizing therapeutics in women's health by developing innovative gynecological prosthetics. Utilizing advanced technologies like artificial intelligence and 3D printing, FemTherapeutics aims to improve treatment options for women. The company's flagship product is the world's first customizable vaginal pessary, designed to address Pelvic Floor Disorders (PFD) such as pelvic organ prolapse and urinary incontinence. This AI-driven platform allows healthcare providers to create tailored medical devices that fit individual anatomical features, enhancing comfort and effectiveness. FemTherapeutics is preparing for biocompatibility testing and clinical studies, with plans for a commercial launch in the third quarter of 2024. The company also intends to expand its technology to other areas of women's health, including maternal health and oncology.

• Employees8
• Founded2022
• Annual Revenue$1000000
• Total Funding$1850000